ROHTO Pharmaceutical Co., Ltd. Investing to Develop Novel Solution for
Urinary Incontinence Symptoms, Venturing into New Values, Products, and
Businesses in the Healthcare Sector.
Announcement of Investment in Australis Scientific Pty Ltd. a Harvard Medical
School Health Tech Fellowship Spin-Out Technology; In-Confidence™ Smart
Patch for Creating Solutions for symptoms of Urinary Incontinence.
Oct 26, 2023
ROHTO Pharmaceutical Co., Ltd. (Head Office: Osaka City, Osaka, President: Masashi Sugimoto) is pleased to announce its position as lead investor in the Series Seed of Australis Scientific Pty Ltd. (Representative Director: Nicky Agahari CEO & Founder), aimed at creating the In-Confidence™ Smart Patch a discreet solution for managing urinary incontinence symptoms.
The agreement was reached on 25th October 2023.
Background and Objectives.
Australis Scientific Pty Ltd. is a cutting-edge health tech venture incubated
at the Harvard Innovation Lab and is developing the In-Confidence™ Smart
Patch for the management of urinary incontinence symptoms. It has achieved
a significant milestone by successfully closing a Series Seed funding round
and winning the Harvard President’s Innovation Challenge. Rohto Pharmaceutical
Co., Ltd. is at the forefront of this round, demonstrating a clear vision
dedicated to serving the aging population. Their role as principal investor
highlights their unwavering commitment to meet the dynamic healthcare demands
of Japan and Asian countries.
Urinary incontinence poses significant health concerns, affecting the quality
of life of millions of patients globally. Australis Scientific Pty Ltd.
has developed the ingenious In-Confidence™ Smart Patch technology, seamlessly
incorporating percutaneous tibial nerve stimulation (PTNS) therapy to manage
acute and chronic urinary frequency, urgency and nocturia symptoms. This
breakthrough solution offers immense promise in mitigating the distressing
symptoms of urinary incontinence.
Australis Scientific Pty Ltd. is dedicated to revolutionizing urinary incontinence
management, combining state-of-the-art digital biomarker tracking, digital
therapeutics, medical devices, and telehealth clinical services into a
full stack solution that is the In-Confidence™ Smart Patch. With Rohto's
strategic support, Australis Scientific Pty Ltd. is poised to expedite
the development and deployment of the In-Confidence™ Smart Patch, ultimately
making a significant impact on the lives of incontinent patients around
the world. For more information on Australis Scientific Pty Ltd. Please
visit their website at InConfidence.IO.